National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Pancreatic Cancer Treatment (PDQ®)     
Last Modified: 06/13/2008
Health Professional Version
Changes to This Summary (06/13/2008)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Stage I and II Pancreatic Cancer 1

The separate treatment sections for the treatment of stage I, stage IIA, and stage IIB pancreatic cancer were combined into one section.

Stage III Pancreatic Cancer 2

This section was extensively revised.

Stage IV Pancreatic Cancer 3

Added text 4 to include gemcitabine and erlotinib as an alternative to the standard treatment option of chemotherapy with gemcitabine (cited Kulke et al. as reference 14).


Table of Links

1http://cancer.gov/cancertopics/pdq/treatment/pancreatic/HealthProfessional/39.c
dr#Section_39
2http://cancer.gov/cancertopics/pdq/treatment/pancreatic/HealthProfessional/75.c
dr#Section_75
3http://cancer.gov/cancertopics/pdq/treatment/pancreatic/HealthProfessional/89.c
dr#Section_89
4http://cancer.gov/cancertopics/pdq/treatment/pancreatic/HealthProfessional/92.c
dr#Section_92